|6.14||-0.46 / -6.97%|
Data as of 4:00pm ET
|6.25||+0.11 / +1.79%|
The 2 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 24.00, with a high estimate of 32.00 and a low estimate of 16.00. The median estimate represents a +290.88% increase from the last price of 6.14.
The current consensus among 2 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.